☆ 4.7 Article

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

CARDIOVASCULAR DIABETOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Nutrition & Dietetics

Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis

Doudou Li et al.

Summary: This study aimed to summarize the health outcomes related to circulating TMAO concentrations. It identified 6 associations with highly suggestive evidence, suggesting that TMAO may be a novel biomarker for human health conditions including all-cause mortality, hypertension, cardiovascular diseases, diabetes mellitus, cancer, and kidney function.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

Anzhu Wang et al.

Summary: This study elucidates the potential mechanisms of action of SGLT2 inhibitors from a systemic and holistic perspective, providing new ideas for future studies on the pharmacological mechanisms of cardiorenal protection by SGLT2 inhibitors.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites

Dongmei Wang et al.

Summary: Type 2 diabetes is associated with gut microbiota dysbiosis and disturbed microbial metabolites, and oral glucose-lowering drugs may improve host health by modifying the gut microbiome and gastrointestinal metabolites. Understanding how antidiabetic agents shape the gut microbiome is crucial for optimizing treatment and guiding probiotic therapy.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure

Nan Li et al.

Summary: This study found that high plasma TMAO levels were associated with poor prognosis in patients with AMI complicated by HF, especially in those with higher hsCRP levels.

ESC HEART FAILURE (2022)

添加到收藏夹

Article Endocrinology & Metabolism

SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study

Min Xu et al.

Summary: The study identified the causal roles of SGLT2 inhibition in choline metabolites, which may influence type 2 diabetes and coronary artery disease through different pathways.

DIABETES CARE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski et al.

Summary: This study investigated the effects of empagliflozin on patients following acute myocardial infarction, showing significant reductions in NT-proBNP and improvements in echocardiographic parameters.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota

Le Deng et al.

Summary: The study showed that EMPA can ameliorate T2DM-related diabetic nephropathy by altering the gut microbiota, especially by reducing LPS-producing bacteria and increasing SCFA-producing bacteria.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study

Nan Li et al.

Summary: This study aimed to investigate the association between changes in levels of trimethylamine N-oxide (TMAO) and its precursors and the prognosis of patients with acute myocardial infarction (AMI). The study found that patients with high levels of TMAO and choline at admission and follow-up showed an increased risk of major adverse cardiovascular events (MACE).

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability

Yen Chin Koay et al.

Summary: The study found that changes in the microbiome induced by both 'healthy' and 'unhealthy' diets can increase plasma TMAO levels in mice. Interestingly, TMAO can be directly oxidized in the gut. However, there was no direct association of plasma TMAO with the extent of atherosclerosis in two well-accepted mouse models of the disease.

CARDIOVASCULAR RESEARCH (2021)

添加到收藏夹

Editorial Material Urology & Nephrology

Clinical Implications of an Acute Dip in eGFR after SGLT2 Inhibitor Initiation

Hiddo J. L. Heerspink et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction

Mohammad A. Almesned et al.

Summary: The gut metabolite TMAO has prognostic value in STEMI patients, and its levels post-PCI fluctuate, which may have prognostic implications for infarct size, especially in patients with impaired renal function.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome

Clemens Ringel et al.

Summary: The study found that plasma levels of TMAO are not independently associated with atherosclerosis, but are related to obesity and diabetes. In terms of long-term mortality, TMAO plasma levels are independent predictors for patients with suspected coronary artery disease.

ATHEROSCLEROSIS (2021)

添加到收藏夹

Article Medical Laboratory Technology

Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction

Zengxiang Dong et al.

Summary: The level of TMAO is closely associated with the risk of HFpEF and is an independent risk factor in patients with HFpEF. TMAO is also correlated with BUN, creatinine, and NT-proBNP in HFpEF patients.

LABORATORY MEDICINE (2021)

添加到收藏夹

Article Psychology, Clinical

Assessment of trimethylamine N-oxide (TMAO) as a potential biomarker of severe stress in patients vulnerable to posttraumatic stress disorder (PTSD) after acute myocardial infarction

Andreas Baranyi et al.

Summary: This study aimed to explore the role of trimethylamine N-oxide (TMAO) as a potential biomarker for predicting PTSD symptomatology in acute myocardial infarction (AMI) patients. The results showed that elevated TMAO levels immediately after AMI might indicate severe stress in PTSD-vulnerable patients. However, there was no significant correlation found between depression and TMAO levels after 6 months post-AMI.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study

Khalid Bin Waleed et al.

Summary: The study showed that in NSTEMI patients, higher levels of plasma TMAO were associated with multivessel disease and higher risk scores, suggesting TMAO as an independent predictor of coronary atherosclerotic burden in NSTEMI.

REVIEWS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Medical Laboratory Technology

Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction

Zengxiang Dong et al.

Summary: The study confirmed significantly elevated plasma levels of TMAO in HFpEF patients compared to controls, and identified a relationship between TMAO and HFpEF risk.

LABORATORY MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial

Norbert J. Tripolt et al.

AMERICAN HEART JOURNAL (2020)

添加到收藏夹

Article Medical Laboratory Technology

Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort

Arne Gessner et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk

Yoriko Heianza et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Review Biotechnology & Applied Microbiology

The gut microbiota and its interactions with cardiovascular disease

Hui Xu et al.

MICROBIAL BIOTECHNOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days

C. Schneider et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction

Fei Guo et al.

BMC CARDIOVASCULAR DISORDERS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Trimethylamine N-Oxide Was Not Associated With 30-Day Left Ventricular Systolic Dysfunction in Patients With a First Anterior ST-Segment Elevation Myocardial Infarction After Primary Revascularization: A Sub-analysis From an Optical Coherence Tomography Registry

Jinying Zhou et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

添加到收藏夹

Article Medical Laboratory Technology

Determination of Trimethylamine-N-oxide by a Simple Isocratic High-Throughput Liquid-Chromatography Tandem Mass-Spectrometry Method

Dietmar Enko et al.

CLINICAL LABORATORY (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide

Hussein Al-Rubaye et al.

CURRENT PROBLEMS IN CARDIOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients

Dingxu Gong et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI

Yasushi Matsuzawa et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction

Zhaoxue Sheng et al.

AMERICAN JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction

Yu Tan et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF

Toru Suzuki et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

Dustin M. Lee et al.

CARDIOVASCULAR DIABETOLOGY (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats

Tomasz Huc et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis

Gabriele Giacomo Schiattarella et al.

EUROPEAN HEART JOURNAL (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies

Yoriko Heianza et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure

Chelsea L. Organ et al.

CIRCULATION-HEART FAILURE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort

Vichai Senthong et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease

Catharina Missailidis et al.

PLOS ONE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure

W. H. Wilson Tang et al.

JOURNAL OF CARDIAC FAILURE (2015)

添加到收藏夹

Article Biochemical Research Methods

Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry

Zeneng Wang et al.

ANALYTICAL BIOCHEMISTRY (2014)

添加到收藏夹

Review Urology & Nephrology

The Gut Microbiome, Kidney Disease, and Targeted Interventions

Ali Ramezani et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.